EUVIMEDEUVIMED entdecken
Crossref

Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis

Yan Luo iD, Chong-Ming Xu, Bo Luo, Gai Liang, Qu Zhang iD

Journal of Pharmacy and Pharmacology · 2023

DOI: 10.1093/jpp/rgad008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Yan Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Abdominal Radiotherapy, Hubei Provincial Cancer Hospital, Wuhan, China. Hauptthemen laut MEDLINE: Melitten, Colorectal Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The primary goal of the current study was to investigate the effect of melittin on colorectal cancer (CRC).

Methods

The viability of cancer cells was tested using the MTT assay, and the apoptosis of tumour cells was assayed using Annexin V/PI staining in vitro or TUNEL staining in vivo. The in vivo toxicity and efficacy of melittin were assessed in a xenograft mouse model.

Results

Melittin inhibited the viability of CRC cell lines and induced apoptosis in SW480 cells by regulating apoptosis-related proteins. Melittin triggered endoplasmic reticulum (ER) stress and caused an imbalance in calcium homeostasis in SW480 cells. An absence of melittin triggered ER stress via the calcium chelating agent BAPTA/AM, and the IP3R inhibitor 2-aminoethoxydiphenyl borate (2-APB) impaired melittin-induced apoptosis in SW480 cells. Melittin treatment suppressed tumour growth but did not affect the body weight of SW480 tumour-bearing mice. Unlike cisplatin and 5-fluorouracil, melittin treatment did not change the biochemical and haematological parameters of the tumour-bearing mice. Finally, in these mice, melittin treatment induced ER stress, which was then blocked by BAPTA/AM, whilst 2-APB impaired the growth inhibitory effect of melittin.

Conclusion

Melittin treatment inhibits CRC progression by inducing ER stress and an imbalance in calcium homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelittenColorectal NeoplasmsHumansAnimalsMiceCalciumApoptosisEndoplasmic Reticulum StressCell Line, TumorEgtazic Acid

Stichwörter der Autor:innen

GRP78calcium homeostasiscolorectal cancerendoplasmic reticulum stressmelittin

Substanzen

MelittenCalcium1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acidEgtazic Acid

Autor:innen und Institutionen

  • Department of Abdominal Radiotherapy, Hubei Provincial Cancer Hospital, Wuhan, China.
  • Colorectal Cancer Clinical Medical Research Center of Hubei Province, Wuhan, China.
  • Colorectal Cancer Clinical Medical Research Center of Wuhan, China.

ORCID-Profile: Yan Luo, Qu Zhang

Zitieren

APA

Luo, Y., Xu, C. M., Luo, B., Liang, G., & Zhang, Q. (2023). Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad008

Vancouver

Luo Y, Xu CM, Luo B, Liang G, Zhang Q. Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad008

BibTeX
@article{Luo2023,
  author = {Luo, Yan and Xu, Chong-Ming and Luo, Bo and Liang, Gai and Zhang, Qu},
  title = {Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2023},
  doi = {10.1093/jpp/rgad008}
}
Kostenlos starten →